Hairy Cell Leukemia (HCL)

Also known as: Hairy Cell Leukemia / Leukemia, Hairy Cell / Hairy cell leukaemia / Hairy-cell Leukemia / HCL / Hairy cell leukemia not having achieved remission / Hairy cell leukemia (disorder) / Hairy cell leukemia (morphologic abnormality) / Leukemic reticuloendotheliosis / Leukaemic reticuloendotheliosis

DrugDrug NameDrug Description
DB00242CladribineA purine antimetabolite used for the management of relapsing forms of Multiple Sclerosis (MS), used in patients who have not responded to or who were unable to tolerate alternative MS drugs.
DB00034Interferon alfa-2aA form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses.
DB00105Interferon alfa-2bA form of recombinant human interferon used to treat hepatitis B and C infection, genital warts, hairy cell leukemia, follicular lymphoma, malignant melanoma, and AIDs-related Kaposi's sarcoma.
DB12688Moxetumomab pasudotoxA CD22-specific antibody conjugated to a truncated exotoxin used to treat relapsed or refractory hairy cell leukemia in patients who have already been treated with a purine nucleoside analog and one other treatment.
DB00552PentostatinAn adenosine deaminase inhibitor used to treat hairy cell leukemia.
DrugDrug NamePhaseStatusCount
DB00316Acetaminophen1Active Not Recruiting1
DB00945Acetylsalicylic acid1Active Not Recruiting1
DB01234Dexamethasone1Active Not Recruiting1
DB01075Diphenhydramine1Active Not Recruiting1
DB00927Famotidine1Active Not Recruiting1
DB12688Moxetumomab pasudotox1Active Not Recruiting1
DB12688Moxetumomab pasudotox1Completed1
DB12688Moxetumomab pasudotox1Unknown Status1
DB16038PLX83941Terminated1
DB12146Rigosertib1Completed1
DB00073Rituximab1Active Not Recruiting1
DB11703Acalabrutinib1 / 2Active Not Recruiting1
DB12121Entospletinib1 / 2Completed1
DB08935Obinutuzumab1 / 2Completed1
DB09037Pembrolizumab1 / 2Active Not Recruiting1
DB06769Bendamustine2Active Not Recruiting1
DB11967Binimetinib2Recruiting2
DB00242Cladribine2Active Not Recruiting1
DB00242Cladribine2Completed1
DB00242Cladribine2Recruiting1
DB11718Encorafenib2Recruiting1
DB15223Flotetuzumab2Withdrawn1
DB09053Ibrutinib2Active Not Recruiting1
DB00034Interferon alfa-2a2Completed1
DB08935Obinutuzumab2Active Not Recruiting1
DB00552Pentostatin2Active Not Recruiting1
DB00073Rituximab2Active Not Recruiting2
DB00073Rituximab2Completed1
DB00073Rituximab2Recruiting2
DB08881Vemurafenib2Active Not Recruiting2
DB08881Vemurafenib2Recruiting1
DB00242Cladribine2 / 3Recruiting1
DB12688Moxetumomab pasudotox3Completed1
DB17366MB-102 CD123 CARNot AvailableEnrolling by Invitation1